cystatin C cystatin C

Similar documents
Package nephro. February 23, 2015

Chapter 6: Limitations of Various Formulae and Other Ways of Assessing GFR in the Elderly: Is There a Role for Cystatin C?

Estimated GFR Based on Creatinine and Cystatin C

Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study

Nierfunctiemeting en follow-up van chronisch nierlijden

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

Renal Function Tests. Carmella L. D Addezio, DO, MS, FACOI, LTC, USAF, MC

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Calculating the stage of Renal Disease

Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Albuminuria versus GFR as markers of diabetic CKD progression

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

AMOEBA (ISSN: )

What is creatinine? The kidneys maintain the blood creatinine in a normal range. Creatinine has been found to be a fairly reliable indicator of kidney

Creatinine (serum, plasma)

Renal function estimation: the implications for clinical practice. Iefke Drion

FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES

FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES

Renal Disease in Type 2 Diabetes Mellitus

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working

Graham Beastall. Outline of Talk

Dialysis Patients' Bill of Rights and Responsibilities

VKA in Dialysis: Navigating between Scylla and Charybdis. An De Vriese Nephrology & Infectious Diseases AZ Sint-Jan Brugge

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

Save the Vein: What Nurses Need to Know. Objectives. Importance of Vein Preservation. Why Focus on Vein Preservation? Chronic Kidney Disease

Diabetes and the Kidneys

Improvement of Diagnosis Coding by Analysing EHR and Using Rule Engine: Application to the Chronic Kidney Disease

Serum Creatinine Levels During and After Long-term Treatment with Cyclosporine A in Patients with Severe Atopic Dermatitis

Nutrition and Chronic Kidney Disease

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function

High Blood pressure and chronic kidney disease

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet

NUTRITIONAL REQUIREMENTS OF PERITONEAL DIALYSIS. J. Kevin Tucker, M.D. Brigham and Women s Hospital Massachusetts General Hospital

Overweight and Obesity in Nevada. Overweight and Obesity in Nevada. Public Health Issue. Overview. Background BRFSS. Objective 9/5/2013

Prediction of Kidney Disease Progression in Patients with Diabetes

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

Peritoneal Dialysis Adequacy. Suzanne Watnick, MD Associate Professor of Medicine Training Program Director Oregon Health & Science University

Update in Contrast Induced Nephropathy

Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC. Feb 27, 2015

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Your Kidneys: Master Chemists of the Body

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

GROWTH HORMONE THERAPY

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Assessment of kidney function in type 2 diabetes

Diagnosis, classification and staging of chronic kidney disease

Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

When Stopping Dialysis Treatment Is Your Choice. A Guide for Patients and Their Families

How To Diagnose And Treat Hyperphosphatemia

High Blood Pressure and Kidney Disease

Chapter 23. Composition and Properties of Urine

Ground Zero: 1997

Transcription:

[1,2] 1991 2000 (USRDS) 2005 ( 2004 2005 ) 2001 (National Kidney Foundation, NKF) K-DOQI (1) (glomerular filtration rate, GFR) 3 (2) 60 ml/min/1.73m 2 3 [3-5] ( 1) 113 (serum creatinine) (Ketoacidosis) (degradation) trimethoprim cimetidine (creatinine clearance, CCr) [6,7] cystatin C Cystatin C 13 cystatin C cystatin C cystatin C cystatin C CRP cystatin C cystatin C ( ) 96 19 2 45

1. Cockcroft-Gault (140-Age) Weight Ccr(ml/min) 72 Scr ( 0.85 if female) Ccr Scr mg/dl Age year Weight kg 2. Abbreviated MDRD Study Estimated GFR (ml/min/1.73m2) = 186 (Scr) 1.154 (Age) 0.203 ( 0.742 if female) ( 1.212 if black) = 175 (Standarized Scr) 1.154 (Age) 0.203 ( 0.742 if female) ( 1.212 if black) 2005( ) 7 3. Schwartz 4. Counahan-Barratt GFR= 0.55 Height (cm) Scr (mg dl) 5. GFR= 1440 0.43 Height (cm) Scr (mg dl) 1. cystatin C [8-12] (inulin) ( 99m Tc-DTPA 51 Cr-EDTA iohexol 125 I-iothalamate ) 24 1440 ( 1) 24 24 46 96 19 2

1. K-DOQI GFR(mL/min/1.73m 2 ) 90 60 89 30 59 15 29 15 24 Cockcroft-Gault MDRD(Modification of Diet in Renal Disease) study ( 1) Cockcroft-Gault 1973 249 30 130ml/min [7,13,14] Cockcroft-Gault 140 ( ) ( ) 72 0.85 Cockcroft-Gault Cockcroft-Gault Cockcroft-Gault Cockcroft-Gault MDRD Study 1999 1628 2005 ( ) [7,15,16] MDRD Study Cockcroft-Gault ( ) [17-19] MDRD Study GFR 90 ml/min/1.73m 2 Cockcroft-Gault 60 18 [20-22] MDRD Study [23] (www.kdoqi.org) MDRD Study abbreviated MDRD Study MDRD Study Schwartz Counahan-Barratt ( 1) Schwartz Counahan-Barratt 96 19 2 47

48 96 19 2 Schwartz 324 57.7% 40.6 18 44 70.1% 45 64 23.8% 65 74 4.6% 75 1.5% 7.4% 1 2.2% 2 2.8% 3 1.5% 4 0.9% 14.2% 91 (26.2%) 2762 71% 18 44 25.1% 45 64 56% 65 74 13.4% 75 5.5% 14% 8.5% ( ) 0.3% ( ) 0.3% ( ) 7.9% ( ) 5.2% ( ) 1.2% 8.5% 24% 91 6000 15 6.9% 71.4% 25% 8% 1.6 [24] 80 50 1.5 24 30 ( 90 120 ) ( 1.4 1.5 ) 24 [7,23] ( 38.7%) ( 30.3%) ( 6.2%) ( 1.8%) ( 1.1%)

(65 ) ( ) ( ) [25] 1. Coresh J, Astor BC, Greene T, et al: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41(1): 1-12. 2. United States Renal Data System. Excerpts from the 2000 US Renal Data System Annual Data Report: Atlas of end stage renal disease in the United States. Am J Kidney Dis 2000; 36: S1-S279. 3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-S266. 4. Levy AS, Coresh J, Bakl E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-47. 5. Levey AS, Eckardt KU, Tsukamoto Y, et al: Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100. 6. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992; 38(10): 1933-53. 7. Stevens LA, Coresh J, Greene T, et al: Assessing kidney function-measured and estimated glomerular filtration rate. New Engl J Med 2006; 345: 2473-83. 8. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-6. 9. Grubb AO: Cystatin C properties and use as diagnostic marker. Adv Clin Chem 2000: 35: 63-99. 10. Sjostrom P, Tidman M, Jones I: Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 2005; 65: 111-24. 11. Keevil BG, Kilpartrick ES, Nichols SP, et al: biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-9. 12. Knight EL, Verhave JC, Spiegelman D, et al: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-21. 13. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41. 14. Sokoll LJ, Russell RM, Sadowski JA, et al: Establishment of creatinine clearance reference values for older women. Clin Chem 1994; 40: 2276-81. 15. Levey AS, Bosch JP, Lewis JB, et al: for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130(6): 461-70. 16. Myers GL, Miller WG, Coresh J, et al: Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the Nation Kidney Disease Education Program. Clin Chem 2006; 52: 5-18. 17. Froissart M, Rossert J, Jacquot C, et al: Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function. J Am Sco Nephrol 2005; 16: 763-73. 18. Verhave JC, Fesler P, Ribstein J, et al: Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-41. 19. Cirillo M, Anastasio P, De Santo JG: Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 2005; 20: 1791-8. 20. Poggio ED, Wang X, Greene T, et al: Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-66. 21. Rule AD, Larson TS, Bergstralh EJ, et al: Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney diseae. Ann Intern Med 2004; 141: 929-37. 22. Zuo L, Ma YC, Zhou YH, et al: Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 463-72. 23. Rosner MH, Bolton WK: Core curriculum in nephrology. Renal function testing. Am J Kidney Dis 2006; 47: 174-83. 24. Hsu CC, Hwang SJ, Wen CP, et al: High prevalence and low awareness of CKD in Taiwan: A study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 2006; 48: 727-38. 25. Levey AS, Stevens LA, Hostetter T. Automatic reporting of estimated glomerular filtration rate just what the doctor ordered. Clin Chem 2006; 52: 2188-93. 96 19 2 49